BPC-157 for Cats

📄 5 PubMed citations

Cats are the least-studied of all pet-peptide searches. Here is the honest picture: no feline study exists, cats metabolize drugs differently, and what that means.

🔬 Cats are not small dogs. They have distinct drug-metabolism quirks, so extrapolating from other species is especially risky. We state the feline evidence gap plainly and focus on what to ask a veterinarian.

🧪 Buy BPC-157 (Arginine Salt) at Swiss Chems →

Code HIGHPEP10 — 10% off regular-priced items

Feline BPC-157 studies

Nearest species data (dogs, PK)

Published feline doses

Mechanism of Action

How It Works

🧬

Repair mechanism (non-feline)

BPC-157 promotes tendon, ligament and gut healing in rodent models (PMID 21030672, 38980576). None of this was tested in cats.

🐈

Cats metabolize differently

Cats have reduced glucuronidation and are famously sensitive to compounds other species tolerate. Extrapolating a dog or human peptide dose to a cat is especially unsafe.

🔬

The feline unknown

A PubMed search for "BPC-157 cat/feline" returns zero results (2026). There is no feline pharmacokinetic, efficacy, or safety data, and no established dose.

Data

What the Data Shows

Rodent repair studies

mechanistic

Multiple

Nearest-species PK (dogs)

beagles

Feline BPC-157 studies

PubMed, 2026

⚠️ There is no published feline dose for BPC-157, and cats’ unusual drug metabolism makes extrapolation from dogs or humans especially risky. We will not print a cat dose. "Veterinarians who work with peptides" exist — a feline-savvy vet is the right place to start, not an online chart.

Bottom Line

Key Takeaways

✅ What We Know

BPC-157 shows tissue-repair activity in rodent tendon, ligament and gut models (PMID 21030672, 20225319, 38980576).
The nearest available species data is a canine (beagle) pharmacokinetic study (PMID 36588717).
Cats have distinctive drug metabolism (reduced glucuronidation) and heightened sensitivity to many compounds.
Some integrative/holistic veterinarians will discuss peptides case by case.

⚠️ What We Don't Know

No feline study of BPC-157 exists (PubMed: 0 results, 2026).
No established or safe feline dose; dog/human extrapolation is especially dangerous in cats.
Feline safety and metabolism of BPC-157 are entirely unstudied.
Even owner anecdotes are far rarer for cats than for dogs.

FAQ

Frequently Asked Questions

Is BPC-157 safe or effective for cats?

There is no feline data at all — no efficacy, safety, or pharmacokinetic study of BPC-157 in cats (PubMed: 0 results, 2026). Because cats metabolize many drugs differently from dogs and humans, extrapolating a dose is especially risky. This is a "consult a cat-savvy veterinarian" situation, not a self-dosing one.

Are there veterinarians who work with peptides for cats?

Some integrative or holistic veterinarians will discuss peptides on a case-by-case basis. That is the right channel for a cat, since there is no published feline protocol to follow.

Why is there so little on cats?

Research and even owner experimentation have concentrated on dogs, which dominate pet-peptide interest. Cats are both less studied and physiologically less forgiving, so the evidence gap is wider.

🧪 Buy BPC-157 (Arginine Salt) — Research Grade

Swiss Chems publishes third-party HPLC COAs for selected products — vendor-published, a claim to verify. Deep-linked to the BPC-157 (Arginine Salt) product page.

Buy BPC-157 (Arginine Salt) at Swiss Chems →

Code HIGHPEP10 — 10% off regular-priced items

Affiliate links — support HighPeptides at no extra cost.